Sign In
Buy NNVC
$1.31
-0.0100 (-0.758%)
At Close: Jun 23, 2026
NNVC Stock: The COVID-19 Drug News That Has NanoViricides Rocketing Today
09:37am, Tuesday, 02'nd Mar 2021
NanoViricides (NNVC) stock is on the rise Tuesday after revealing results from the company's drug candidates to treat the coronavirus. The post NNVC Stock: The COVID-19 Drug News That Has NanoViricide
SHELTON, CT / ACCESSWIRE / March 2, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicine te
NanoViricides' Broad-Spectrum Antiviral Drug Candidate Shows Encouraging Action In Preclinical Studies For COVID-19
07:40am, Monday, 08'th Feb 2021
NanoViricides Inc (NYSE: NNVC) has reported data from animal studies evaluating its broad-spectrum antiviral drug candidate NV-CoV-2 to treat COVID-19 infections. The treatment candidate was wel
Small Caps Daily Features NanoViricides' Rapid Advancement to Clinical Trials for its COVID-19 Therapy
11:49am, Wednesday, 18'th Nov 2020
New York, New York--(Newsfile Corp. - November 18, 2020) - NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on
Clene Nanomedicine, Inc. Raises an Oversubscribed $42.5M Series D
12:00am, Thursday, 27'th Aug 2020
Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on the development of first-in-class nanocatalysts for the treatment of b
LD Micro: Announces Preliminary List of Presenters for the LD-500
05:43pm, Thursday, 06'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
NanoViricides, Inc. Raises $11.5 Million Through Public Offering After Positive Test Results For COVID-19 Drug
03:48pm, Thursday, 23'rd Jul 2020
The Company's successful fundraising and inclusion in the Russell Microcap(R) Index comes after a series of promising test results for its COVID-19 drug candidates Shelton, Connecticut--(Newsfile Corp
NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020
10:15am, Tuesday, 21'st Jul 2020
SHELTON, CT / ACCESSWIRE / July 21, 2020 / NanoViricides, Inc.
SAN FRANCISCO, July 20, 2020 -- Hagens Berman urges investors in NanoViricides, Inc. (NNVC) to submit their losses now. The firm is investigating possible securities fraud, and.
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Announces Investigation of NanoViricides, Inc. (NNVC) on Behalf of Investors
PHILADELPHIA, July 16, 2020 -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of NanoViricides, Inc. (“NanoViricides” or the.
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Announces Investigation of NanoViricides, Inc. (NNVC) on Behalf of Investors
Cashing in on coronavirus: Small biopharma company NanoViricides sees stock soar on treatment claims
11:00am, Tuesday, 14'th Jul 2020
As the coronavirus was spreading in China, a small biopharma company, NanoViricides, claimed it was close to clinical trials for a treatment. A CNBC investigation found the 15-year-old company has nev
NanoViricides Closes On $11.5 Million Underwritten Public Offering of Common Stock
10:30am, Monday, 13'th Jul 2020
SHELTON, CT / ACCESSWIRE / July 13, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomed
NanoViricides Prices $10.0 Million Underwritten Public Offering of Common Stock
10:15am, Thursday, 09'th Jul 2020
SHELTON, CT / ACCESSWIRE / July 9, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines pl
